Ivermectin

The potential use of ivermectin as an anti-cancer drug is an area of active research. Some studies have shown that it can inhibit the proliferation of cancer cells and induce cell death. It may work by suppressing the activity of certain proteins, such as PAK1, which are involved in cancer cell growth and survival.
However, it's important to note that these findings are preliminary and more research is needed to confirm the effectiveness of using ivermectin in cancer treatment. While there have been some promising results in laboratory and animal studies, there are no large-scale clinical trials to support its use in humans.
In summary, while there is some evidence to suggest that ivermectin may have anti-cancer properties, more research is needed to determine its safety and efficacy as a cancer treatment. It is not currently approved for this use, and any use of the drug for this purpose should be done under the supervision of a healthcare professional.

Read more research about Ivermectin and cancer

Read more at NIH